免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

FDA 510(k)

Dexcom G7 持續血糖監測系統

K 號:K213919 · 2022-12-07

申請人Dexcom, Inc.
決定日期2022-12-07
產品代碼QBJ
諮詢委員會CH
決定相當於

器材摘要

Dexcom G7 Continuous Glucose Monitoring System is the device name listed in this FDA 510(k) record. The listed applicant is Dexcom, Inc.. It received FDA 510(k) clearance on 2022-12-07 under 510(k) number K213919. The device is classified under product code QBJ. It was reviewed by the CH advisory panel. FDA Decision: Substantially Equivalent.

常見問題

What is the Dexcom G7 Continuous Glucose Monitoring System?

Dexcom G7 Continuous Glucose Monitoring System is a medical device that received FDA 510(k) clearance on 2022-12-07. The listed applicant is Dexcom, Inc.. The 510(k) number is K213919.

When did Dexcom G7 Continuous Glucose Monitoring System receive FDA 510(k) clearance?

Dexcom G7 Continuous Glucose Monitoring System received FDA 510(k) clearance on 2022-12-07, under 510(k) number K213919.

Who is the listed applicant for Dexcom G7 Continuous Glucose Monitoring System?

FDA 510(k) 記錄將 Dexcom, Inc. 列為申請人。這並不單獨確立設備製造商。

What is the FDA product code for Dexcom G7 Continuous Glucose Monitoring System?

The FDA product code for Dexcom G7 Continuous Glucose Monitoring System is QBJ.

相關臨床試驗

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

其他以 Dexcom, Inc. 為申請人之記錄

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

查看所有 25 項裝置 →

相關器械(代碼:QBJ)

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊,請始終參閱官方記錄。

↑